A3 adenosine receptors modulate hypoxia-inducible factor-1alpha expression in human A375 melanoma cells.
about
Purinergic signalling and cancerA review of the past, present, and future directions of neoplasiaNeoplasia: Where We Have Been and Where We Are GoingHuman brain endothelial cells are responsive to adenosine receptor activation.A1 adenosine receptors play an essential role in protecting the embryo against hypoxia.Investigational A₃ adenosine receptor targeting agents.Embryonic caffeine exposure induces adverse effects in adulthoodRole of JunB in adenosine A2B receptor-mediated vascular endothelial growth factor production.Adenosine receptors in wound healing, fibrosis and angiogenesis.Adenosine receptors and cancer.Adenosine receptor targeting in health and disease.Production of adenosine by ectonucleotidases: a key factor in tumor immunoescape.The role of HIFs in ischemia-reperfusion injury.Adenosine and adenosine receptors in the immunopathogenesis and treatment of cancer.5'-ectonucleotidase mediates multiple-drug resistance in glioblastoma multiforme cells.A3 Adenosine Receptors as Modulators of Inflammation: From Medicinal Chemistry to Therapy.Hydrogen sulfide inhibits IL-8 expression in human keratinocytes via MAP kinase signaling.TRAIL up-regulation must be accompanied by a reciprocal PKCε down-regulation during differentiation of colonic epithelial cell: implications for colorectal cancer cell differentiation.A(2B) and A(3) adenosine receptors modulate vascular endothelial growth factor and interleukin-8 expression in human melanoma cells treated with etoposide and doxorubicin.Transcriptional regulation of urokinase-type plasminogen activator receptor by hypoxia-inducible factor 1 is crucial for invasion of pancreatic and liver cancer.Neoplasia: An Anniversary of Progress.Therapeutic potency of pharmacological adenosine receptor agonist/antagonist in angiogenesis, current status and perspectives.The Hypoxia-Adenosine Link during Intestinal Inflammation.Preclinical In Vitro and In Vivo Evaluation of [18F]FE@SUPPY for Cancer PET Imaging: Limitations of a Xenograft Model for Colorectal Cancer.Adenosinergic Signaling Alters Natural Killer Cell Functional Responses
P2860
Q24618782-52A23A8B-B88F-40F1-AC5D-19AB64231F6AQ28389391-C0EC83BC-326F-464D-A33E-B6A21E8523B2Q28395095-14B27822-067B-4DEB-9AEA-D22F10723020Q35136806-DB1F744A-1AB3-4D75-8120-BDBDA6065E5AQ35834361-4F06622F-A483-45BF-82F6-2BA9EF300A7EQ36731575-C050811E-3B8B-4398-920E-6AE32DE538A2Q37139819-90D67DC7-1FB6-4D39-91CD-ED1F3089E2B9Q37405416-460CC989-A88F-43B2-B06B-6CE685E44008Q37565195-1EBD9E5C-0840-42A6-972F-8F4016EADA05Q37565200-28DAE5A8-C722-41E8-8EA8-C61C2E58DF8CQ37948081-1463B38F-F2C6-43CE-8769-4DA99A9D4A4EQ38058320-ED39D85D-24E9-4D5F-BAD4-E5F3FFF1DCE4Q38989135-3CC3A7DD-4703-4D95-942D-A2E720B12AC0Q39148961-7097B4CC-81CD-464D-B1BB-279328A9715AQ39308023-96BFC977-4644-4983-9CDE-49EC260E16FAQ39418010-8D1FE310-813B-4F70-AB87-637144827D25Q39545584-111A8364-56E5-4445-B0D3-69A83B57038DQ39564445-4AC2F71C-1133-48B0-BE94-B93E70024DF3Q39793029-851A9F42-2734-4DD2-8445-8B9D9A26103FQ39889775-7000574E-CD0E-46DF-A1C6-54D64CCCAA9DQ46932476-6194102C-C42C-4DA5-BB04-000B44D9B01BQ48150516-B1D05D79-F8B9-4D6C-9B0F-ADC3195B456CQ48191363-2712512E-1996-4CA4-A3EA-A41A59312349Q52581914-E2087F04-F59A-42C2-9DD6-DC4D4354EE04Q58697979-229CA073-72A4-4DC8-8BD0-AB406BBFFB6C
P2860
A3 adenosine receptors modulate hypoxia-inducible factor-1alpha expression in human A375 melanoma cells.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
A3 adenosine receptors modulat ...... in human A375 melanoma cells.
@en
type
label
A3 adenosine receptors modulat ...... in human A375 melanoma cells.
@en
prefLabel
A3 adenosine receptors modulat ...... in human A375 melanoma cells.
@en
P2093
P2860
P356
P1433
P1476
A3 adenosine receptors modulat ...... in human A375 melanoma cells.
@en
P2093
Annalisa Benini
Edward Leung
Katia Varani
Pier Andrea Borea
Pier Giovanni Baraldi
Stefania Gessi
Stefania Merighi
Stephen MacLennan
P2860
P304
P356
10.1593/NEO.05334
P577
2005-10-01T00:00:00Z